Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.
2.

Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.

Alp S, Akova M.

Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017002. doi: 10.4084/MJHID.2017.002. eCollection 2017. Review.

3.

Host response to Clostridium difficile infection: Diagnostics and detection.

Usacheva EA, Jin JP, Peterson LR.

J Glob Antimicrob Resist. 2016 Dec;7:93-101. doi: 10.1016/j.jgar.2016.08.002. Epub 2016 Sep 20. Review.

PMID:
27693863
4.

A Review of Management of Clostridium difficile Infection: Primary and Recurrence.

Vincent Y, Manji A, Gregory-Miller K, Lee C.

Antibiotics (Basel). 2015 Sep 24;4(4):411-23. doi: 10.3390/antibiotics4040411. Review.

5.

Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation.

Pilcante J, Rojas P, Ernst D, Sarmiento M, Ocqueteau M, Bertin P, García M, Rodriguez M, Jara V, Ajenjo M, Ramirez P.

Rev Bras Hematol Hemoter. 2015 Nov-Dec;37(6):388-94. doi: 10.1016/j.bjhh.2015.07.010. Epub 2015 Aug 19.

6.

Follow-up of Pseudomembranous Colitis in Children Using Colonoscopy: A Case Report.

Zhao Q, Yuan H, Hu H, Yan MQ.

West Indian Med J. 2015 Sep;64(4):435-7. doi: 10.7727/wimj.2014.252. Epub 2015 Apr 17.

7.

Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.

Erikstrup LT, Aarup M, Hagemann-Madsen R, Dagnaes-Hansen F, Kristensen B, Olsen KE, Fuursted K.

BMJ Open Gastroenterol. 2015 Nov 2;2(1):e000038. doi: 10.1136/bmjgast-2015-000038. eCollection 2015.

8.
9.

WSES guidelines for management of Clostridium difficile infection in surgical patients.

Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GA, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P.

World J Emerg Surg. 2015 Aug 20;10:38. doi: 10.1186/s13017-015-0033-6. eCollection 2015. Review.

10.

Antibiotic Regimen after a Total Abdominal Colectomy with Ileostomy for Fulminant Clostridium difficile Colitis: A Multi-Institutional Study.

van der Wilden GM, Subramanian MP, Chang Y, Lottenberg L, Sawyer R, Davies SW, Ferrada P, Han J, Beekley A, Velmahos GC, de Moya MA.

Surg Infect (Larchmt). 2015 Aug;16(4):455-60. doi: 10.1089/sur.2013.153. Epub 2015 Jun 12.

11.

Trends in Clostridium difficile Disease: Epidemiology and Intervention.

Riddle DJ Dr, Dubberke ER Dr.

Infect Med. 2009;26(7):211-220.

12.

An agent-based simulation model for Clostridium difficile infection control.

Codella J, Safdar N, Heffernan R, Alagoz O.

Med Decis Making. 2015 Feb;35(2):211-29. doi: 10.1177/0272989X14545788. Epub 2014 Aug 11.

13.

Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.

Zanella Terrier MC, Simonet ML, Bichard P, Frossard JL.

World J Gastroenterol. 2014 Jun 21;20(23):7416-23. doi: 10.3748/wjg.v20.i23.7416. Review.

14.

Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Iv EC, Iii EC, Johnson DA.

World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):1-26. doi: 10.4292/wjgpt.v5.i1.1. Review.

15.

Clostridium difficile infection: management strategies for a difficult disease.

Khanna S, Pardi DS.

Therap Adv Gastroenterol. 2014 Mar;7(2):72-86. doi: 10.1177/1756283X13508519. Review.

16.

Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.

Schroeder LF, Robilotti E, Peterson LR, Banaei N, Dowdy DW.

J Clin Microbiol. 2014 Feb;52(2):489-96. doi: 10.1128/JCM.02777-13. Epub 2013 Nov 27.

17.

Treatment Strategies for Recurrent Clostridium difficile Infection.

Leong C, Zelenitsky S.

Can J Hosp Pharm. 2013 Nov;66(6):361-8. Review.

18.

Clostridium difficile Infection in Children: Current State and Unanswered Questions.

Tamma PD, Sandora TJ.

J Pediatric Infect Dis Soc. 2012 Sep;1(3):230-43. doi: 10.1093/jpids/pis071. Epub 2012 Jul 25. Review.

19.

Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB.

Clin Infect Dis. 2013 Jun;56(12):1713-21. doi: 10.1093/cid/cit147. Epub 2013 Mar 13.

20.

Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report.

Shen BJ, Lin SC, Shueng PW, Chou YH, Tseng LM, Hsieh CH.

Onco Targets Ther. 2013;6:25-8. doi: 10.2147/OTT.S40145. Epub 2013 Jan 17.

Supplemental Content

Support Center